/
MDXH
$0.42+$0.01 (+1.87%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$20.9M
51M shares
52-week range
$0.40 – $5.33
0% from low
Exchange
NASDAQ
CS
Change$-119.59
MDxHealth SA Ordinary Shares
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
www.mdxhealth.com- Employees
- 364
- IPO / List date
- Feb 14, 2008
Held by traders on TradeandTell
No one on the platform currently holds MDXH.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in MDXH as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2023-11-14 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded MDXH yet.
